These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9038848)

  • 41. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
    Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
    J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential.
    Wei Y; Zhang C; Zhao P; Yang X; Wang K
    J Inorg Biochem; 2011 Aug; 105(8):1081-5. PubMed ID: 21726771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
    Pereira MJ; Carvalho E; Eriksson JW; Crans DC; Aureliano M
    J Inorg Biochem; 2009 Dec; 103(12):1687-92. PubMed ID: 19850351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
    Nandhini D; Maneemegalai S; Elangovan V; Sekar N; Govindasamy S
    Indian J Biochem Biophys; 1993 Feb; 30(1):73-6. PubMed ID: 8509129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats.
    Wasan KM; Risovic V; Yuen VG; Hicke A; McNeill JH
    Exp Clin Cardiol; 2004; 9(2):125-9. PubMed ID: 19641699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased potency of vanadium using organic ligands.
    McNeill JH; Yuen VG; Dai S; Orvig C
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):175-80. PubMed ID: 8927036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
    Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
    Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bis(maltolato)-oxovanadium (IV)-induced phosphorylation of PKB, GSK-3 and FOXO1 contributes to its glucoregulatory responses (review).
    Vardatsikos G; Mehdi MZ; Srivastava AK
    Int J Mol Med; 2009 Sep; 24(3):303-9. PubMed ID: 19639221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats.
    Sanchez-Gonzalez C; Moreno L; Lopez-Chaves C; Nebot E; Pietschmann P; Rodriguez-Nogales A; Galvez J; Montes-Bayon M; Sanz-Medel A; Llopis J
    Metallomics; 2017 Mar; 9(3):258-267. PubMed ID: 28194470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vanadium and diabetes.
    Poucheret P; Verma S; Grynpas MD; McNeill JH
    Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H; Fujii K; Watanabe H; Tamura H
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats.
    Setyawati IA; Thompson KH; Yuen VG; Sun Y; Battell M; Lyster DM; Vo C; Ruth TJ; Zeisler S; McNeill JH; Orvig C
    J Appl Physiol (1985); 1998 Feb; 84(2):569-75. PubMed ID: 9475867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
    Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
    J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aggravation by vanadium of magnesium deficiency in STZ-induced diabetic rats.
    Bermúdez-Peña MC; López-Chaves C; Llopis J; Guerrero-Romero F; Montes-Bayón M; Sanz-Medel A; Sánchez-González C
    Magnes Res; 2013; 26(2):74-82. PubMed ID: 23823277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
    Majithiya JB; Balaraman R; Giridhar R; Yadav MR
    J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-enhancing vanadium(III) complexes.
    Melchior M; Rettig SJ; Liboiron BD; Thompson KH; Yuen VG; McNeill JH; Orvig C
    Inorg Chem; 2001 Aug; 40(18):4686-90. PubMed ID: 11511216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.